BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K, Mignot E. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 2009;32:175-80. [PMID: 19238804 DOI: 10.1093/sleep/32.2.175] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Kim HC, Lee DA, Lee HJ, Shin KJ, Park KM. Alterations in the structural covariance network of the hypothalamus in patients with narcolepsy. Neuroradiology 2022. [PMID: 35013760 DOI: 10.1007/s00234-021-02878-6] [Reference Citation Analysis]
2 Sadam H, Pihlak A, Kivil A, Pihelgas S, Jaago M, Adler P, Vilo J, Vapalahti O, Neuman T, Lindholm D, Partinen M, Vaheri A, Palm K. Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling. EBioMedicine 2018;29:47-59. [PMID: 29449194 DOI: 10.1016/j.ebiom.2018.01.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
3 Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207. [PMID: 21269851 DOI: 10.1016/j.smrv.2010.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
4 Sakai N, Chikahisa S, Nishino S. Stimulants in Excessive Daytime Sleepiness. Sleep Medicine Clinics 2010;5:591-607. [DOI: 10.1016/j.jsmc.2010.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Hu W, Chen Z. The roles of histamine and its receptor ligands in central nervous system disorders: An update. Pharmacology & Therapeutics 2017;175:116-32. [DOI: 10.1016/j.pharmthera.2017.02.039] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
6 De la Herrán-Arita AK, García-García F. Current and emerging options for the drug treatment of narcolepsy. Drugs 2013;73:1771-81. [PMID: 24122734 DOI: 10.1007/s40265-013-0127-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
7 Yoshikawa T, Nakamura T, Yanai K. Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness. Br J Pharmacol 2021;178:750-69. [PMID: 32744724 DOI: 10.1111/bph.15220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Naganuma F, Yoshikawa T. Organic Cation Transporters in Brain Histamine Clearance: Physiological and Psychiatric Implications. Handb Exp Pharmacol 2021;266:169-85. [PMID: 33641029 DOI: 10.1007/164_2021_447] [Reference Citation Analysis]
9 Shimada M, Miyagawa T, Kodama T, Toyoda H, Tokunaga K, Honda M. Metabolome analysis using cerebrospinal fluid from narcolepsy type 1 patients. Sleep 2020;43:zsaa095. [PMID: 32412602 DOI: 10.1093/sleep/zsaa095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bastianini S, Lo Martire V, Berteotti C, Silvani A, Ohtsu H, Lin J, Zoccoli G. High-amplitude theta wave bursts characterizing narcoleptic mice and patients are also produced by histamine deficiency in mice. J Sleep Res 2016;25:591-5. [DOI: 10.1111/jsr.12404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Panula P, Nuutinen S. The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 2013;14:472-87. [DOI: 10.1038/nrn3526] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
12 Nishino S, Deguzman C, Yamadera W, Chiba S, Kanbayashi T. Neurochemistry and Biomarkers of Narcolepsy and Other Primary and Secondary Hypersomnias. Sleep Medicine Clinics 2012;7:233-48. [DOI: 10.1016/j.jsmc.2012.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Dauvilliers Y, Delallée N, Jaussent I, Scholz S, Bayard S, Croyal M, Schwartz JC, Robert P. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 2012;35:1359-66. [PMID: 23024434 DOI: 10.5665/sleep.2114] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
14 Liu YW, Li J, Ye JH. Histamine regulates activities of neurons in the ventrolateral preoptic nucleus. J Physiol 2010;588:4103-16. [PMID: 20724362 DOI: 10.1113/jphysiol.2010.193904] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
15 Sharma A, Muresanu DF, Patnaik R, Menon PK, Tian ZR, Sahib S, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Skaper SD, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy. Prog Brain Res 2021;266:1-73. [PMID: 34689857 DOI: 10.1016/bs.pbr.2021.06.003] [Reference Citation Analysis]
16 Yoshikawa T, Yanai K. Histamine Clearance Through Polyspecific Transporters in the Brain. Handb Exp Pharmacol 2017;241:173-87. [PMID: 27679412 DOI: 10.1007/164_2016_13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
17 Sadek B, Saad A, Sadeq A, Jalal F, Stark H. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases. Behav Brain Res 2016;312:415-30. [PMID: 27363923 DOI: 10.1016/j.bbr.2016.06.051] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
18 Shan L, Bao AM, Swaab DF. The human histaminergic system in neuropsychiatric disorders. Trends Neurosci 2015;38:167-77. [PMID: 25575625 DOI: 10.1016/j.tins.2014.12.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
19 Romigi A, Vitrani G, Lo Giudice T, Centonze D, Franco V. Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy. Drug Des Devel Ther 2018;12:2665-75. [PMID: 30214155 DOI: 10.2147/DDDT.S101145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
20 Panula P, Sundvik M, Karlstedt K. Developmental roles of brain histamine. Trends Neurosci. 2014;37:159-168. [PMID: 24486025 DOI: 10.1016/j.tins.2014.01.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
21 Nishino S, Mignot E. Wake-Promoting Medications. Principles and Practice of Sleep Medicine. Elsevier; 2011. pp. 510-26. [DOI: 10.1016/b978-1-4160-6645-3.00044-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Schrölkamp M, Jennum PJ, Gammeltoft S, Holm A, Kornum BR, Knudsen S. Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2. J Clin Sleep Med 2017;13:235-43. [PMID: 27855741 DOI: 10.5664/jcsm.6454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
23 Nishino S, Okuro M. Emerging treatments for narcolepsy and its related disorders. Expert Opin Emerg Drugs 2010;15:139-58. [PMID: 20166851 DOI: 10.1517/14728210903559852] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
24 Nishino S, Sagawa Y. The Neurochemistry of Awakening. Science of Awakening. Elsevier; 2010. pp. 229-55. [DOI: 10.1016/s0074-7742(10)93010-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding C, Lecomte J, Schwartz J. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. The Lancet Neurology 2013;12:1068-75. [DOI: 10.1016/s1474-4422(13)70225-4] [Cited by in Crossref: 207] [Cited by in F6Publishing: 62] [Article Influence: 23.0] [Reference Citation Analysis]
26 Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollmächer T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39. [DOI: 10.1038/s41582-019-0226-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 37.7] [Reference Citation Analysis]
27 Hoerbelt P, Ramerstorfer J, Ernst M, Sieghart W, Thomson JL, Hough LB, Fleck MW. Mutagenesis and computational docking studies support the existence of a histamine binding site at the extracellular β3+β3− interface of homooligomeric β3 GABA A receptors. Neuropharmacology 2016;108:252-63. [DOI: 10.1016/j.neuropharm.2016.04.042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
28 Zhang J, Han F. Sleepiness in Narcolepsy. Sleep Medicine Clinics 2017;12:323-30. [DOI: 10.1016/j.jsmc.2017.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Schneider EH, Neumann D, Seifert R. Modulation of behavior by the histaminergic system: Lessons from H1R-and H2R-deficient mice. Neuroscience & Biobehavioral Reviews 2014;42:252-66. [DOI: 10.1016/j.neubiorev.2014.03.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
30 Leibiger J, Fendt M. Behavioral Analysis of Narcoleptic Episodes in Orexin-Deficient Mice. Behav Genet 2014;44:136-43. [DOI: 10.1007/s10519-013-9634-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
31 Mochizuki T, Arrigoni E, Marcus JN, Clark EL, Yamamoto M, Honer M, Borroni E, Lowell BB, Elmquist JK, Scammell TE. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A 2011;108:4471-6. [PMID: 21368172 DOI: 10.1073/pnas.1012456108] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.7] [Reference Citation Analysis]
32 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
33 Melzi S, Morel AL, Scoté-Blachon C, Liblau R, Dauvilliers Y, Peyron C. Histamine in murine narcolepsy: What do genetic and immune models tell us? Brain Pathol 2021;:e13027. [PMID: 34672414 DOI: 10.1111/bpa.13027] [Reference Citation Analysis]
34 Lin JS, Sergeeva OA, Haas HL. Histamine H3 receptors and sleep-wake regulation. J Pharmacol Exp Ther 2011;336:17-23. [PMID: 20864502 DOI: 10.1124/jpet.110.170134] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 7.6] [Reference Citation Analysis]
35 Croyal M, Dauvilliers Y, Labeeuw O, Capet M, Schwartz J, Robert P. Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization. Analytical Biochemistry 2011;409:28-36. [DOI: 10.1016/j.ab.2010.09.045] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
36 Yoshikawa T, Naganuma F, Iida T, Nakamura T, Harada R, Mohsen AS, Kasajima A, Sasano H, Yanai K. Molecular mechanism of histamine clearance by primary human astrocytes. Glia 2013;61:905-16. [PMID: 23505051 DOI: 10.1002/glia.22484] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
37 Schwartz JC. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol 2011;163:713-21. [PMID: 21615387 DOI: 10.1111/j.1476-5381.2011.01286.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 170] [Article Influence: 17.5] [Reference Citation Analysis]
38 Eriksson KS, Sergeeva OA, Haas HL, Selbach O. Orexins/hypocretins and aminergic systems. Acta Physiol (Oxf) 2010;198:263-75. [PMID: 19566795 DOI: 10.1111/j.1748-1716.2009.02015.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
39 Wang JY, Han F, Dong SX, Li J, An P, Zhang XZ, Chang Y, Zhao L, Zhang XL, Liu YN, Yan H, Li QH, Hu Y, Lv CJ, Gao ZC, Strohl KP. Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome. Sleep 2016;39:855-60. [PMID: 26943469 DOI: 10.5665/sleep.5642] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
40 Takasu M, Kubota T, Tsuji T, Kurahashi H, Numoto S, Okumura A. The effects of antihistamines on the semiology of febrile seizures. Brain Dev 2019;41:72-6. [PMID: 30064732 DOI: 10.1016/j.braindev.2018.07.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Bernardino L, Eiriz MF, Santos T, Xapelli S, Grade S, Rosa AI, Cortes L, Ferreira R, Bragança J, Agasse F. Histamine stimulates neurogenesis in the rodent subventricular zone. Stem Cells. 2012;30:773-784. [PMID: 22893458 DOI: 10.1002/stem.1042] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
42 Scammell TE, Jackson AC, Franks NP, Wisden W, Dauvilliers Y. Histamine: neural circuits and new medications. Sleep 2019;42. [PMID: 30239935 DOI: 10.1093/sleep/zsy183] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
43 Naganuma F, Nakamura T, Yoshikawa T, Iida T, Miura Y, Kárpáti A, Matsuzawa T, Yanai A, Mogi A, Mochizuki T, Okamura N, Yanai K. Histamine N-methyltransferase regulates aggression and the sleep-wake cycle. Sci Rep 2017;7:15899. [PMID: 29162912 DOI: 10.1038/s41598-017-16019-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
44 Bastianini S, Silvani A, Berteotti C, Lo Martire V, Cohen G, Ohtsu H, Lin JS, Zoccoli G. Histamine Transmission Modulates the Phenotype of Murine Narcolepsy Caused by Orexin Neuron Deficiency. PLoS One 2015;10:e0140520. [PMID: 26474479 DOI: 10.1371/journal.pone.0140520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
45 Schmidt C, Leibiger J, Fendt M. The norepinephrine reuptake inhibitor reboxetine is more potent in treating murine narcoleptic episodes than the serotonin reuptake inhibitor escitalopram. Behavioural Brain Research 2016;308:205-10. [DOI: 10.1016/j.bbr.2016.04.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Wang Z, Wu J, Wu S, Bao A. High-performance liquid chromatographic determination of histamine in biological samples: The cerebrospinal fluid challenge – A review. Analytica Chimica Acta 2013;774:1-10. [DOI: 10.1016/j.aca.2012.12.041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
47 Guevarra JT, Hiensch R, Varga AW, Rapoport DM. Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility. Nat Sci Sleep 2020;12:709-19. [PMID: 33117007 DOI: 10.2147/NSS.S264140] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Castriotta RJ, Murthy JN. Sleep disorders in patients with traumatic brain injury: a review. CNS Drugs 2011;25:175-85. [PMID: 21062105 DOI: 10.2165/11584870-000000000-00000] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 8.0] [Reference Citation Analysis]
49 Sundvik M, Panula P. Organization of the histaminergic system in adult zebrafish ( Danio rerio ) brain: Neuron number, location, and cotransmitters. J Comp Neurol 2012;520:3827-45. [DOI: 10.1002/cne.23126] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
50 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
51 Teske JA, Billington CJ, Kotz CM. Hypocretin/orexin and energy expenditure. Acta Physiol (Oxf) 2010;198:303-12. [PMID: 20070282 DOI: 10.1111/j.1748-1716.2010.02075.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
52 Thakkar MM. Histamine in the regulation of wakefulness. Sleep Med Rev 2011;15:65-74. [PMID: 20851648 DOI: 10.1016/j.smrv.2010.06.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 9.3] [Reference Citation Analysis]
53 Hitchcott PK, Menicucci D, Frumento S, Zaccaro A, Gemignani A. The neurophysiological basis of excessive daytime sleepiness: suggestions of an altered state of consciousness. Sleep Breath 2020;24:15-23. [PMID: 31140116 DOI: 10.1007/s11325-019-01865-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Kanbayashi T, Kodama T, Kondo H, Satoh S, Inoue Y, Chiba S, Shimizu T, Nishino S. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009;32:181-7. [PMID: 19238805 DOI: 10.1093/sleep/32.2.181] [Cited by in Crossref: 118] [Cited by in F6Publishing: 85] [Article Influence: 9.1] [Reference Citation Analysis]
55 Sundvik M, Panula P. Interactions of the orexin/hypocretin neurones and the histaminergic system. Acta Physiol (Oxf) 2015;213:321-33. [PMID: 25484194 DOI: 10.1111/apha.12432] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
56 Baronio D, Gonchoroski T, Castro K, Zanatta G, Gottfried C, Riesgo R. Histaminergic system in brain disorders: lessons from the translational approach and future perspectives. Ann Gen Psychiatry 2014;13:34. [PMID: 25426159 DOI: 10.1186/s12991-014-0034-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
57 Chen L, Brown RE, McKenna JT, McCarley RW. Animal models of narcolepsy. CNS Neurol Disord Drug Targets 2009;8:296-308. [PMID: 19689311 DOI: 10.2174/187152709788921717] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
58 Verhoeven WMA, Egger JIM, Janssen PKC, van Haeringen A. Adult male patient with severe intellectual disability caused by a homozygous mutation in the HNMT gene. BMJ Case Rep 2020;13:e235972. [PMID: 33310825 DOI: 10.1136/bcr-2020-235972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 John J, Thannickal TC, McGregor R, Ramanathan L, Ohtsu H, Nishino S, Sakai N, Yamanaka A, Stone C, Cornford M, Siegel JM. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann Neurol 2013;74:786-93. [PMID: 23821583 DOI: 10.1002/ana.23968] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 7.7] [Reference Citation Analysis]
60 Vernet C, Arnulf I. Narcolepsy with long sleep time: a specific entity? Sleep 2009;32:1229-35. [PMID: 19750928 DOI: 10.1093/sleep/32.9.1229] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
61 Reading PJ. Update on narcolepsy. J Neurol 2019;266:1809-15. [DOI: 10.1007/s00415-019-09310-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
62 Rye DB. Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment. Sleep 2012;35:1315-7. [PMID: 23024426 DOI: 10.5665/sleep.2098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Yoshikawa T, Nakamura T, Yanai K. Histamine N-Methyltransferase in the Brain. Int J Mol Sci 2019;20:E737. [PMID: 30744146 DOI: 10.3390/ijms20030737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
64 Haas HL, Lin J. Waking with the hypothalamus. Pflugers Arch - Eur J Physiol 2012;463:31-42. [DOI: 10.1007/s00424-011-0996-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
65 Mignot E. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 855-872.e7. [DOI: 10.1016/b978-0-323-24288-2.00089-1] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
66 Tyree SM, de Lecea L. Optogenetic Investigation of Arousal Circuits. Int J Mol Sci 2017;18:E1773. [PMID: 28809797 DOI: 10.3390/ijms18081773] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
67 Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW. Control of sleep and wakefulness. Physiol Rev 2012;92:1087-187. [PMID: 22811426 DOI: 10.1152/physrev.00032.2011] [Cited by in Crossref: 700] [Cited by in F6Publishing: 590] [Article Influence: 70.0] [Reference Citation Analysis]
68 Ishizuka T, Murotani T, Yamatodani A. Action of Modafinil Through Histaminergic and Orexinergic Neurons. Sleep Hormones. Elsevier; 2012. pp. 259-78. [DOI: 10.1016/b978-0-12-394623-2.00014-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
69 Cheng L, Liu J, Chen Z. The Histaminergic System in Neuropsychiatric Disorders. Biomolecules 2021;11:1345. [PMID: 34572558 DOI: 10.3390/biom11091345] [Reference Citation Analysis]
70 de Biase S, Nilo A, Gigli GL, Valente M. Investigational therapies for the treatment of narcolepsy. Expert Opin Investig Drugs 2017;26:953-63. [PMID: 28726523 DOI: 10.1080/13543784.2017.1356819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
71 Kripke DF. Is suvorexant a better choice than alternative hypnotics? F1000Res 2015;4:456. [PMID: 26594338 DOI: 10.12688/f1000research.6845.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
72 Shan L, Hofman MA, van Wamelen DJ, Van Someren EJ, Bao AM, Swaab Dick F. Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases. Sleep 2012;35:713-5. [PMID: 22547898 DOI: 10.5665/sleep.1838] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
73 Sundvik M, Kudo H, Toivonen P, Rozov S, Chen YC, Panula P. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J 2011;25:4338-47. [PMID: 21885652 DOI: 10.1096/fj.11-188268] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
74 Crocker A, Sehgal A. Genetic analysis of sleep. Genes Dev 2010;24:1220-35. [PMID: 20551171 DOI: 10.1101/gad.1913110] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
75 Hirai N, Nishino S. Recent Advances in the Treatment of Narcolepsy. Curr Treat Options Neurol 2011;13:437-57. [DOI: 10.1007/s11940-011-0137-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
76 Shan L, Fronczek R, Lammers GJ, Swaab DF. The tuberomamillary nucleus in neuropsychiatric disorders. Handb Clin Neurol 2021;180:389-400. [PMID: 34225943 DOI: 10.1016/B978-0-12-820107-7.00024-0] [Reference Citation Analysis]
77 Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep 2015;7:51-61. [PMID: 26045680 DOI: 10.2147/NSS.S56077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
78 Calik MW. Update on the treatment of narcolepsy: clinical efficacy of pitolisant. Nat Sci Sleep 2017;9:127-33. [PMID: 28490912 DOI: 10.2147/NSS.S103462] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 6.2] [Reference Citation Analysis]
79 Valko PO, Gavrilov YV, Yamamoto M, Reddy H, Haybaeck J, Mignot E, Baumann CR, Scammell TE. Increase of histaminergic tuberomammillary neurons in narcolepsy: Histaminergic Neurons. Ann Neurol 2013;74:794-804. [DOI: 10.1002/ana.24019] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 10.6] [Reference Citation Analysis]
80 Wang P, Li Q, Dong X, An H, Li J, Zhao L, Yan H, Aritake K, Huang Z, Strohl KP, Urade Y, Zhang J, Han F. Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia. Sleep 2021;44:zsaa234. [PMID: 33175978 DOI: 10.1093/sleep/zsaa234] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Franco P, Dauvilliers Y, Inocente CO, Guyon A, Villanueva C, Raverot V, Plancoulaine S, Lin JS. Impaired histaminergic neurotransmission in children with narcolepsy type 1. CNS Neurosci Ther 2019;25:386-95. [PMID: 30225986 DOI: 10.1111/cns.13057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
82 Usui T, Nakazawa A, Okura T, Deguchi Y, Akanuma S, Kubo Y, Hosoya K. Histamine elimination from the cerebrospinal fluid across the blood-cerebrospinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT/SLC29A4). J Neurochem 2016;139:408-18. [DOI: 10.1111/jnc.13758] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
83 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
84 Scammell TE, Mochizuki T. Is low histamine a fundamental cause of sleepiness in narcolepsy and idiopathic hypersomnia? Sleep 2009;32:133-4. [PMID: 19238797 DOI: 10.1093/sleep/32.2.133] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
85 Burgess CR. Histamine and orexin in the control of arousal, locomotion, and motivation. J Neurosci 2010;30:2810-1. [PMID: 20181578 DOI: 10.1523/JNEUROSCI.0045-10.2010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
86 Barateau L, Jaussent I, Roeser J, Ciardiello C, Kilduff TS, Dauvilliers Y. Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence. Sleep 2021;44:zsab012. [PMID: 33476396 DOI: 10.1093/sleep/zsab012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]